Rigel Pharmaceuticals
NASDAQ: RIGL

Clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders

Sector: Biopharmaceuticals
Company Status: Public
Investment Status: Current